Latest News About - obstetrical and gynaecological devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, January 19, 2021

3:46:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Dr Williams explained: “At some point in the future those cells that we're collecting and we create with banking, the technology will exist to make them into stem cells, and to make new animals,” External link

telegraph Sunday, January 17, 2021 7:13:00 AM CET

Mike Campbell commented: "Galaxy Pharma was an early pioneer in the emerging fertility industry within Pakistan and has not only established itself as the clear leader in the country but has also positioned itself as a comprehensive service and products supplier," External link

4-traders Friday, January 15, 2021 2:36:00 PM CET

Mike Campbell concluded: "While the market that is being served is comparatively small currently, we believe the opportunity is sizable and Galaxy Pharma holds a unique position in the marketplace. Galaxy Pharma has been actively involved in supporting the development of IVF centers with 21 out of the current 25 IVF centers being complete turnkey projects accomplished by Galaxy. They are also involved in accredited training programs for gynecologists and have created local joint ventures with 21 IUI clinics that actively perform approximately 5,000 IUI cycles each year. Interestingly, these IUI facilities have andrology labs, and Galaxy's partners have already been trained for ovarian stimulation, IUI and IVF. Collectively, this is where we, and Galaxy, see a great opportunity to bring INVOcell into these centers as an additional or alternative option beyond IUI, as well as take advantage of the larger number of OBGYN's to help increase available capacity, and care, to the underserved patients in need of a more advanced treatment option," External link

4-traders Friday, January 15, 2021 2:36:00 PM CET

Jeroen Tas said: “At Philips we are leading digital transformation in healthcare, with a portfolio that includes solutions for both professionals and consumers to support parents-to-be through pregnancy and the first years of their baby’s life,” External link

4-traders Thursday, January 14, 2021 10:03:00 AM CET

Jan Kirsten added: “With Philips, we have a partner that shares our belief in the potential of digital health to improve the patient experience, bringing a wealth of experience in connected care to our offering. Together, this collaboration will push our two companies to think beyond tomorrow and discover new solutions that can empower people to realize their dreams of parenthood,” External link

4-traders Thursday, January 14, 2021 10:03:00 AM CET

Alex Aravanis said: “A comprehensive approach here is to do nearly all the genes implicated in cancer in a single test. Having one test that allows you to do all or a large number of them is really the way to get the most access for patients,” “For many of these tests, it may only be 1% or 2% of lung cancer patients that are eligible. And then if that test isn’t done as an individual test, they may not get access to it. So we think there’s a tremendous efficiency to a comprehensive approach” External link

clinicalomics Tuesday, January 12, 2021 5:23:00 PM CET

Phil Febbo said: “The growing use of PARP inhibitor therapeutics to broader populations of patients with HRD is paramount in our work with Myriad Genetics as the future of healthcare looks to molecular-based testing to improve patient outcomes through standardized, best in class testing,” External link

clinicalomics Tuesday, January 12, 2021 5:23:00 PM CET

Holly Dickson said: “This ruling is a victory for all Arkansans and a decisive repudiation of Arkansas politicians’ ongoing crusade to deny people the right to make their own medical decisions and force them to continue pregnancies against their will,” External link

breitbart-com Saturday, January 9, 2021 2:49:00 AM CET

Jennifer Martin said: “I am incredibly excited to join Omnia Medical,” External link

massdevice Thursday, December 31, 2020 4:10:00 PM CET

David McNally said: “The timely response from the FDA provides additional information regarding the agency’s position on potential predicate RASD systems along with the intended use and the technology embodied in the Enos system. These insights will help guide our regulatory strategy so that we can most efficiently allocate our resources to achieve U.S. market clearance,” External link

4-traders Wednesday, December 30, 2020 1:33:00 PM CET

Michael Klein said: “We’re excited to start this very important clinical trial with Dr. Kesari as Lead Investigator, an accomplished researcher and clinician who ranks in the top 1% of neuro-oncologists and neurologists in the U.S., 1 ” External link

globenewswire Wednesday, December 30, 2020 12:10:00 AM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.